Novel drug candidates targeting Alzheimer's disease: ethical challenges with identifying the relevant patient population.

Authors:
Gustavsson E; Raaschou P; Lärfars G; Sandman L; Juth N.

Journal:
J Med Ethics

Publication Year: 2021

DOI:
10.1136/medethics-2021-107304

PMCID:
PMC8394767

PMID:
34117127

View on PubMed View on PMC View Publisher
Journal Information

Full Title: J Med Ethics

Abbreviation: J Med Ethics

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Ethics

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
COVID-19 vaccine boosters for young adults: a risk benefit assessment and ethical analysis of manda…
Bardosh K; Krug A; Jamrozik E and 6 more (2024) - Transparency Score: 4/6
Professional virtue of civility and the responsibilities of medical educators and academic leaders.
McCullough LB; Coverdale J; Chervenak FA. (2023) - Transparency Score: 3/6
The harm principle, personal identity and identity-relative paternalism.
Wilkinson D. (2023) - Transparency Score: 3/6
Where is knowledge from the global South? An account of epistemic justice for a global bioethics.
Pratt B; de Vries J. (2023) - Transparency Score: 3/6
Whose models? Which representations? A response to Wagner.
Hardman D; Hutchinson P. (2023) - Transparency Score: 3/6
View All Papers from This Journal
Transparency Score
2/6
0.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Competing interests: None declared."

Evidence found in paper:

"Funding: This study was funded by Stockholm County Council."

Protocol Registration
Open Access
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025